TOP 10 INSIGHTS IN CLINICAL SUPPLY CHAIN & LOGISTICS
BEST OF 2023
|
|
|
|
Genentech’s Clinical Supply Center, which opened in 2022 in South San Francisco, earned the company an ISPE Facility of the Year Award in the Pharma 4.0 category.This Q&A, the third in a series featuring FOYA winners, explores the strategy behind a central manufacturing site for clinical manufacturing.
|
|
|
|
Packaging and labeling decisions made in advance of platform selection may have inadvertently “designed out” critical opportunities to enhance supply management, clinical operations, and participant safety. Learn how when leveraged early, the right RTSM vendor can answer several critical IP packaging decisions and streamline clinical trial startup.
|
|
|
|
There is a great opportunity for clinical supply chain practitioners to learn from their commercial peers. By adapting and adopting the right commercial best practices, clinical supply chains become more effective, cost-efficient, and agile in delivering the right treatments to the right patients.
|
|
|
|
By offering guidance on optimizing ROI from extensive data collections and various endpoints in clinical studies, learn how IRT technology can enhance the data-driven approach for sponsors.
|
|
|
|
Appropriate manufacturing and timely delivery of investigational products are essential for the successful execution of clinical trials. This article shares best practices working with CDMOs as well as phase-appropriate GMP of the clinical supply.
|
|
|
|
Explore the industry impact of rapidly evolving vaccinology, the power of next-gen science and technology, and how finding the right supply chain partner has never been more essential.
|
|
|
|
While it is challenging to make precise predictions for clinical trial supplies,applying Bayesian statistics will help. This article shares steps to plan your Bayesian approach and how it helps to reduce waste and prevent shortages.
|
|
|
|
Handling development and manufacturing challenges for orphan drugs requires experience, expertise and scalable technologies, along with a flexible and agile supply chain.
|
|
|
|
If you're a pre-commercial bio/pharma looking ahead to commercial stage, evaluating partnerships are faced with making key decisions around which capabilities to outsource, the degree of data access and ownership, and which external partners are the right fit. Here are four key actions to consider.
|
|
|
|
Did you know that 75% of clinical research sites keep track of their inventory using spreadsheets and paper? Understand the challenges sites face when handling inventory and how to overcome them.
|
|
|
|